Abbott Laboratories stock analysis
Abbott Laboratories passes 6 of 8 fundamental tests, a score of 8/10. On the daily chart it is in a sideways range, RSI 59, 21% below its 52-week high: range-bound: no edge either way. Its own volatility puts the likely range at $96.99–$113.43 a month from now and $79.97–$137.57 in a year (68% bands). The last two days of news lean bullish (1 positive, 0 negative stories).
Fundamentals 8/10
- Market cap
- $181.5 B
- P/E · forward
- 33.8 · 17.3
- PEG · P/B
- 1.9 · 3.6
- ROE · net margin
- +11% · +12%
- Revenue · earnings growth
- +13% · -48%
- Debt / equity
- 63%
- Dividend · beta
- 2.4% · 0.6
- Next results
- 21 Oct 2026
- ✕ ROE above 15%
- ✓ Net margin above 10%
- ✓ Revenue growing over 10%
- ✕ Earnings growing
- ✓ Debt/equity under 100%
- ✓ Positive free cash flow
- ✓ Forward P/E under trailing (earnings expected up)
- ✓ PEG under 2
Swing technicals (daily)
- Trend
- sideways · 50d above 200d
- RSI(14)
- 59
- 20 / 50 / 200-day avg
- $100.98 / $105.87 / $102.81
- 20-day breakout
- above $105.46 · below $95.06
- ATR(14)
- $2.33 (2.2% a day)
- 52-week range
- $81.97 – $132.03
- Return 3m · 6m · 1y
- +3% · +8% · -18%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | $96.99 – $113.43 (-8% / +8%) |
| 3 mo | $91.59 – $120.12 (-13% / +15%) |
| 6 mo | $86.59 – $127.06 (-17% / +21%) |
| 1 year | $79.97 – $137.57 (-24% / +31%) |
Analysts (26): strong buy, mean target $120.72 (+15%)
From its own volatility (27% a year), no drift assumed: what its swings allow, not a forecast.
Abbott Laboratories news · last two days
News lean: Bullish · 1 up · 0 down- 12h agoAnalysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)The Globe and Mail
- 14h agoAbbott Laboratories stock heads into the next Xetra session at EUR 93.01Ad Hoc News
- 27h agoAbbott Laboratories (ABT) Launches Ensure Max Protein As Undervalued View Faces A Fresh TestSimply Wall St.
- 29h agoCountdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks
- 2d agoAbbott Laboratories stock outperforms competitors on strong trading dayMarketWatch
- 3d agoMedtronic Pays More Today. Abbott Raises Its Dividend Faster. Which Stock Wins?24/7 Wall St.
- 3d agoAbbott stock tests pivotal support at $101.82 with mixed technical signals: weekly analysistradersunion
- 4d agoAbbott Laboratories (ABT) Is A Key Player In Closed Loop NeurostimulationSimply Wall St.
- 4d agomHealth Solutions Market Forecasts Growth from $109.05B (2026) to $275.44B by 2031, Profiling Philips, Medtronic, Abbott, Dexcom, ResMed & 20 Other Key PlayersGlobeNewswire
- 4d agoGlobal Bioelectronic Medicine Device Market 2026 | Capitalize on 17% CAGR Through 2030 as Medtronic, Abbott, Boston Scientific and LivaNova Advance Closed-Loop NeurostimulationGlobeNewswire
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.